A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia

<div>Patients treated with the nutritional supplement PPT5<i>α</i> presented a higher percentage of terminal hair than those in the placebo group both in the frontal and parietal areas at a six-month visit. (a) Differences in the median percentages of terminal hair from the baseline visit (<i>T</i> = 0) to the end of the study (<i>T</i> = 6) in the frontal and the parietal areas for the placebo and the intervention group obtained from trichoscopic photographs. A <svg height="10.2124pt" id="M24" style="vertical-align:-3.42943pt" version="1.1" viewbox="-0.0498162 -6.78297 7.83752 10.2124" width="7.83752pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M570 304C570 398 525 448 414 448C385 448 343 445 312 434L329 511L321 518C297 504 262 482 244 460L233 411C195 397 159 381 128 358L135 332C160 347 189 360 224 373L111 -147C97 -210 84 -218 17 -231L13 -257L254 -247L259 -218L233 -216C183 -212 177 -202 189 -142L218 -1C238 -10 266 -12 283 -12C351 3 429 48 483 105C543 168 570 242 570 304ZM482 289C482 161 380 33 304 33C278 33 248 51 233 69L303 396C326 400 352 403 369 403C428 403 482 380 482 289Z"></path></g></svg> value &lt; 0.05 was considered statistically significant. (b) Macroscopic and microscopic images at the baseline (<i>T</i> = 0) visit and at the end (<i>T</i> = 6) of the study, for both the intervention and control groups.</div>

Dermatologic Therapy

fig2

Figure 2

Figure 2: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia 

Figure 2 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia 